The ability of a Japanese quail fibrosarcoma cell line to support the replication of avian metapneumoviruses belonging to the 3 subgroups A (14/1 virus), B (Colorado virus), and C (Hungary virus) enabled the development of assays for the detection and evaluation of virus-specific antibodies. On the basis of the results of enzyme-linked immunosorbent assay (ELISA), plaque reduction neutralization assay (PRNA), immunofluorescent assay (IFA), and Western blot analysis, some degree of antigenic cross-reactivity was observed between prototype viruses belonging to each of the 3 subgroups A, B, and C. The antigen produced in QT-35 cells was found to be superior with respect to its reactivity with virus-specific antibodies, as determined when used in ELISA and IFA. Standardization of both the input virus and the virus-specific antibodies in PRNA enabled a more detailed analysis of the antigenic relationship between these viruses. Specifically, it was observed that 14/1 virus shared more neutralizing regions with Hungary and Colorado viruses than did either of these viruses with 14/1 virus. In addition, Hungary virus shared comparatively fewer neutralizing epitopes with the Colorado virus than did 14/1 virus. Western blot analysis of the reactivity patterns of virus antigen, produced in QT-35 cells, with subgroup-specific antibodies identified a cross-reactive protein migrating at approximately 18 kD. These assays and the information from the Western blot will enable further analysis of avian metapneumovirus isolates to determine antigenic relationships.
Avian metapneumovirus is a respiratory pathogen in turkeys and chickens of all ages, with pheasants and guinea fowl also being susceptible. 3, 11, 22 It is a member of the Paramyxoviridae family, and virus isolates have been segregated into at least 3 different subgroups based on sequence analysis. 2, 17, 25, 26 Molecular typing using the G gene has allowed for the assignment of British isolates before 1994 to group A, whereas most continental strains have been assigned to group B. Sequence analysis of the matrix protein gene demonstrated that the US isolate, APV/CO, was distinct from European strains and was therefore assigned to group C. The extensive molecular heterogeneity observed between strains has hampered the development of widely applicable molecular methods for virus detection, and there have been few attempts to correlate antigenic and genomic typing. Early comparisons of different strains by cross-neutralization tests using polyclonal antisera suggested that there was a single serotype, 13 and to date, this has not been disproved, although substantial antigenic heterogeneity between strains has been clearly demonstrated.
From an epidemiological standpoint, there is evidence that the reservoir for this virus may reside in waterfowl and wild birds. 11 Therefore, the possibility From the Canadian Food Inspection Agency, National Centre for Foreign Animal Disease, 1015 Arlington Street, Winnipeg, Manitoba R3E 3M4, Canada.
exists that more subgroups may emerge, and in fact, this may have recently happened in France. 27 It is noteworthy that metapnuemoviruses have recently been isolated from young children with respiratory ailments. 28 It has been hypothesized that the extensive antigenic and molecular variability demonstrated by these viruses may play a role in their ability to cross species barriers by providing a large and diverse virus repertoire.
Antigenic characterization of avian metapneumoviruses has been carried out using monoclonal antibodies and polyclonal antisera in a variety of assay systems, including enzyme linked immunosorbent assay (ELISA), immunofluorescent assay (IFA), virus neutralization assay, and Western blot analysis. [5] [6] [7] 9, [12] [13] [14] [15] [20] [21] [22] However, despite information in the literature regarding the antigenic relatedness of avian metapneumoviruses, it has been difficult to interpret and compare results because of the variability in antigen preparation and lack of standardization in some serum-based assays. For example, various virus strains have been amplified for use in IFA and serum neutralization assays in either chicken embryo fibroblast or Vero cells, neither of which are optimal cell substrates. 4, 12, 15 Furthermore, antigens for use in ELISA formats have reportedly been prepared by a variety of methods, including detergent extraction, freeze-thawing of infected cells, or polyethylene glycol precipitation of clarified infected culture supernatants. 6, 10, 15, 27 To address the cell sub-strate issue, a Japanese quail fibrosarcoma cell line (QT-35) was evaluated and found to be suitable for avian metapneumovirus propagation, titration, and serological detection using IFA. 19, 23, 24 These cells have the advantage of being avian in origin, thus ensuring authentic posttranslational modification of viral proteins, and are easy to maintain and standardize. Avian metapneumoviruses have also demonstrated the ability to produce plaques in QT-35 cells, thereby allowing a more precise analysis of virus populations and the antigenic relationship between strains.
The objective of the work described in this manuscript was to develop assay systems using the QT-35 cell substrate to evaluate, on both an antigenic and a molecular level, the cross-reactivity between different metapneumovirus strains. Although a limited number of virus strains were evaluated at this time, the results clearly indicated that these assay systems are useful for the analyses of other avian metapneumovirus strains.
Materials and methods
Cells and virus. African green monkey kidney (Vero) cells a were routinely propagated in Eagle minimal essential medium (MEM) b supplemented with 10% gamma-irradiated fetal bovine serum (␥-FBS) c and 2 mM L-glutamine. b Japanese quail fibrosarcoma (QT-35) cells d were routinely propagated in Dulbecco modified Eagle medium formulated with 4,500 mg/liter glucose (hgDMEM) and supplemented with nonessential amino acids (NEAA), 10% ␥-FBS, and 2 mM L-glutamine. The passage level of QT-35 cells was carefully monitored, and only cells between passages 54 and 75 were used.
Avian metapneumovirus strains e 14/1 (subgroup A), Hungary 657/4 (subgroup B), and Colorado (subgroup C) were propagated in either Vero or QT-35 cells, as previously described, to produce virus for inoculum or purification. 23 In brief, confluent cell monolayers were infected at a multiplicity of infection of 0.05 by adsorbing a small amount of inoculum for 1 hr in a humidified CO 2 incubator at 37 C, after which the appropriate cell culture medium supplemented with 2% ␥-FBS was overlaid. Incubation proceeded until the maximum cytopathogenic effect was observed.
Antiserum production. Commercial turkeys, f determined to be free of Salmonella, Mycoplasma meleagridis, Mycoplasma synovae, avian influenza, Newcastle disease virus, and pneumovirus, were shipped at 1 day of age and acclimated for 28-29 days before inoculation. On day 0, a group of 10 turkeys was inoculated with a total of 10 5 tissue culture infective doses (TCID 50 ) of each virus by administering 1 drop of inoculum in each eye, nares, and mouth. All turkeys were boosted on day 12 with the same inoculum via the route previously described, with the exception of the Colorado inoculum, which was administered intramuscularly into the pectoral muscle. Each group of turkeys was bled before inoculation (prebleed), and then they were separately caged and handled to prevent cross-contamination. On days 22-26, blood was collected in a humane manner and processed to obtain virus-specific antiserum.
Immunofluorescent assay. Polyclonal antisera specific for strains 14/1, Hungary, and Colorado were evaluated for their ability to detect 14/1 viral antigens in both Vero and QT-35 cells. As described previously, the procedure was to first seed each well of a 96-well plate with 5.0 ϫ 10 4 QT-35 or 2.0 ϫ 10 4 Vero cells prepared in medium used for routine propagation of each respective cell line. 23 After a 24-hr incubation at 37 C in a humidified CO 2 incubator, the medium was removed and replaced with a dilution of virus inoculum that was previously determined to result in between 5 and 10 syncytia per well or with the diluent medium (cell control). The virus diluent medium was identical to that used for cell propagation, except that it contained only 2% ␥-FBS. The plate was then further incubated at 37 C in a humidified CO 2 incubator for 3 days, after which the cell monolayers were fixed with cold (Ϫ30 C) methanol for 10 min at 25 C. The solvent was then removed and the plate dried at 37 C for 1 hr. To detect viral antigens, 65 l of each antiserum, diluted 1:10 or 1:50 in either PBS containing 0.05% Tween-20 (PBS-T) or PBS containing 0.05% Tween-20 and 5% nonfat milk (PBS-TB), was incubated with infected and uninfected cells (triplicate wells of each) for 1 hr at 37 C in a humidified incubator. The plate was then washed with PBS-T, and 65 l of fluorescein-labeled, turkey-specific goat IgG (H ϩ L) antibody, diluted in the same manner as the primary antibody, was applied to each well. b After 1 hr of incubation at 37 C in a humidified incubator, the unbound antibody was removed by washing with PBS-T, and the wells were immediately examined by fluorescent microscopy. A positive reaction was noted where at least 2 of 3 infected wells exhibited 1 or more fluorescent foci, and 0 of 3 uninfected wells had no fluorescent foci.
Enzyme-linked immunosorbent assay. Coating antigen for ELISA was prepared using 2 different methods. The first method was as previously described, where uninfected and 14/1-infected Vero and chicken embryo fibroblast (CEF) cell lysates were prepared by treatment with 0.01% NP-40, g followed by low-speed centrifugation to remove insoluble material. 15 The second method involved semipurification of 14/1, Colorado, and Hungary viruses from infected cells by lowspeed clarification to remove cell debris, followed by centrifugation at 100,000 ϫ g through a 20% su-crose cushion for 2 hr at 15 C. The resulting pellets from both infected and uninfected cell culture supernatants were standardized to a total protein concentration of 1 mg/ml by direct colorimetric determination using bicinchoninic acid according to the manufacturer's instructions. h The ELISA was performed using detergent-extracted antigen as previously described, 13 with the modification that 1 g of positive or negative antigen was applied per well. Plates were coated overnight at 25 C, and 100 l per well was used for all reagents and sera. Serum samples were diluted 1:40 in PBS-T with 4% ␥-FBS, incubated at 25 C with antigen for 1 hr, and then washed off. Bound antibody was detected by addition of a rabbit anti-chicken antibody conjugated to horseradish peroxidase b diluted in PBS-T. After removal of unbound conjugate, the substrate, H 2 O 2 , and the chromagen 0.04 M 2,2-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) b were added. Absorbance was measured at 414 nm in a photometer when a positive control serum reached an absorbance value of 1.0. A positive-negative (P-N) ratio (absorbance of sera in positive antigen-coated wells/absorbance in negative antigen-coated wells) was determined for each serum.
Plaque reduction neutralization assay. A detailed procedure for plaquing avian metapneumoviruses in QT-35 cells was previously described 24 and used to determine the dilution of virus inoculum required to produce between 25 and 50 plaques per well. In brief, QT-35 cells were seeded into 12-well plates at 40,000 cells/cm 2 . After a 24-hr incubation at 37 C, the cell culture fluid was replaced with 500 l of 10-fold serial dilutions for each avian metapneumovirus made in ␣-MEM supplemented with 2.4 g gentamycin/ml, and virus adsorption proceeded for an additional hour. The virus inoculum was then removed and replaced with 2 ml of 1.5% (final) carboxymethyl-cellulose (CMC) h prepared 1:1 with 2ϫ MEM (without phenol red) supplemented with sodium bicarbonate, 9,000 mg glucose/ml, 4 mM L-glutamine, 2% NEAA, 4% ␥-FBS, and 2.4 g gentamycin/ml. Plates were incubated for 13 days in a 37 C, humidified incubator, after which plaques could be observed by light microscopy or easily counted after staining with 0.5% crystal violet-PBS once the CMC overlay was removed by inverting and tapping the plate and rinsing with water.
To perform the plaque reduction neutralization assay (PRNA), an equal volume of virus and antisera were incubated for 1 hr at 37 C before application to the cell monolayer. One antibody unit (AU) of antiserum was defined as the highest dilution of that antiserum that neutralized 25-50 plaques (i.e., 100%) of the homologous virus. Concentrations of 5 and 10 AUs were therefore 5 and 10 times less dilute. The PRNA was performed by first incubating equal volumes of a virus inoculum containing 25-50 plaques with 1, 5, and 10 AUs of each antiserum for 1 hr at 37 C. The mixture was then applied to each well in a 12-well plate format for 1 hr at 37 C, and the remainder of the procedure was as described above.
Western blot analysis. Purified virus preparations, corresponding to each virus strain and standardized to 1 g/l, were solubilized by heating at 95 C for 30 min in a buffer containing 2% (w/v) SDS, 5% ␤-mercaptoethanol, 3% (w/v) glycerol, 0.002% (w/v) bromophenol blue, and 50 mM Tris (pH 6.8). Proteins were resolved by electrophoresis on a 11% (w/v) sodium dodecyl sulfate-polyacrylamide gel and then electrotransferred to a polyvinylidene fluoride membrane. g Nonspecific binding sites were blocked with 5% nonfat milk i -PBS for 30 min at 25 C, followed by incubation with each strain-specific antiserum diluted in PBS-TB for 1 hr at 37 C. Blots were then washed with PBS-T and further incubated with phosphatase-labeled, turkey-specific goat IgG (H ϩ L) antibody. b After extensive washing of the membrane, color was developed using a 5-bromo-4-chloro-3-indolyl-phosphate nitro blue tetrazolium substrate. b
Results
Antigenic cross-reactivity determined by IFA. Strain 14/1 viral antigen produced in either Vero or QT-35 cells could be detected by immunofluorescent staining with 14/1-, Hungary-, and Colorado-specific antisera diluted 1:10 in PBS-T (Table 1) . Under more stringent conditions, where heterologous sera were diluted 1:10 in PBS-TB or 1:50 in PBS-T, immunofluorescent staining was detected only with 14/1 antigen produced in QT-35 cells. As expected, the homologous antibody reacted with 14/1 antigen under all test conditions, and antiserum obtained from a prebleed did not demonstrate fluorescence under any condition.
Antigenic cross-reactivity determined by ELISA. Various antigen preparations were evaluated for their reactivity with specific antisera, and the results are shown in Table 2 . All three 14/1 antigen preparations exhibited significantly higher P-N ratios with homologous antiserum than with the 2 heterologous antisera. The P-N ratio resulting from a reaction of NP-40extracted, Vero-produced 14/1 antigen with both anti-Hungary and anti-Colorado sera was comparatively lower than that exhibited by purified virus prepared in QT-35 cells and the NP-40 extract of CEF-infected cells. Interestingly, the P-N ratio exhibited by the anti-14/1 serum with QT-35-produced virus was significantly less than that resulting from a reaction with NP-40-extracted antigen produced in either CEF or Vero cells.
Antiserum specific for 14/1 also reacted with QT-35-produced Hungary and Colorado viruses, albeit with a lower P-N ratio than that exhibited by the homologous reaction. Two-way cross-reactivity was exhibited by each antiserum and virus combination as indicated by P-N values greater than 1.0. Antigenic cross-reactivity determined by PRNA. The results in Table 3 confirm that the appropriate dilution of each antiserum was selected to represent 1 AU because there were no plaques observed with the homologous virus. Depending on the amount of AU used in the assay, various degrees of cross-neutralization up to 100% were observed. Significant (Ն95% plaque reduction) 2-way neutralization was observed in all cases using 10 AUs of serum, with the exception of anti-Hungary, which was only able to neutralize 41% of the Colorado plaques. Antibodies to 14/1 virus demonstrated the most efficient cross-neutralization because 1 AU was able to neutralize 7% and 95% of Colorado and Hungary virus plaques, respectively, and 5 AUs were able to neutralize 93% and 100%, respectively. However, 14/1 virus could be neutralized only by 10 AUs of anti-Hungary or anti-Colorado serum.
Antigenic cross-reactivity determined by Western blot analysis. In all cases, homologous antiserum specifically reacted with 1 or 2 major viral proteins in the region delineated between the 37-and 50-kD molecular weight markers (Fig. 1 ). Additional faint crossreactivity was detected with minor proteins in this re-gion. Anti-Colorado serum exhibited strong reactivity with 2 major proteins of the 14/1, Colorado, and Hungary viruses migrating at approximately 18 and 70 kD. However, only the 18-kD protein of each virus was also detected with anti-14/1 and anti-Hungary sera.
Discussion
Studies describing the usefulness of QT-35 cells for avian metapneumovirus propagation enabled the development of serological assays that could be used to detect virus-specific antibodies and investigate antigenic cross-reactivity. 23, 24 This was accomplished by evaluating 1 prototype virus from each of the 3 subgroups, along with the corresponding antisera, in a QT-35 cell-based ELISA, IFA, PRNA, and Western blot. Traditionally, subgroup A antigens produced in Vero cells have been used for serological detection of virus in North America. 15 However, the recent emergence of a new avian metapneumovirus subgroup necessitated the development of a modified ELISA using Colorado and Minnesota virus isolates propagated in Vero cells. 6 The rationale for developing and using a QT-35 cell substrate to produce viral antigen was based on a requirement to detect avian metapneumovirus antibodies regardless of the subgroup to which they belonged. It was hypothesized that a more authentic form of virus, with respect to posttranslational protein modifications, would be produced in avian cells, thereby increasing Table 3 . Percent neutralization of 14/1, Hungary, and Colorado viruses using 1, 5, and 10 antibody units of specific serum in a plaque reduction assay. the likelihood that conserved regions would be retained.
The analysis of results from ELISA, IFA, PRNA, and Western blot indicated some degree of serological cross-reactivity between the 3 prototype viruses, even though each assay system detected antibodies with slightly different characteristics. For example, only antibodies with neutralizing ability were measured by the PRNA, and for the most part, the antibody-binding sites were likely conformational in nature. In contrast, antibody-binding sites detected by Western blot anal-ysis likely corresponded to linear epitopes because of the denatured form of the protein. Depending on the method of protein extraction or fixation, IFA and ELISA detected antibodies specific to both conformational and linear epitopes. The fact that antigenic cross-reactivity could be detected by IFA under more stringent assay conditions when using QT-35 cells as compared with Vero cells indicated that the antibodybinding sites were either more numerous or more representative of those presented by the virus in the target species. It was hypothesized that this may be due to the avian origin of the QT-35 cells and, for practical purposes, indicated that the sensitivity of an IFA could be increased by using a QT-35 cell substrate. The specificity of the immunofluorescent staining may also have depended on the virus strain used for infection of the cell substrate. In these studies, 14/1 was selected because it is routinely used in diagnostic laboratories as the ELISA coating antigen. In addition, ELISA cross-reactivity with subgroups B and C virus-specific sera was demonstrated with 14/1 viral antigen produced by either detergent extraction of infected CEF cells or particle purification from infected QT-35 cells.
To make a valid comparison between the cross-reactivities of the antisera, evaluations were carried out by standardizing each serum relative to its ability to neutralize the homologous virus and then using it at 2 different dilutions. This approach has been successfully used to determine the antigenic relationships of isolates belonging to other RNA virus families where the existence of quasispecies has been well documented. 16 As mentioned previously, a variety of assays have been used in the past to compare isolates, but they either have not used standardized reference serum or, if standardized, have evaluated neutralization only at 1 antibody dilution level. [12] [13] [14] [15] Three standard antibody levels of 1.0, 5.0, and 10 AUs were chosen for the present studies to investigate more closely the relatedness of the 3 viruses. The results indicated a distinctive reactivity pattern for each virus with the 3 reference sera. Examination of 1-way neutralization results for each of the antisera demonstrated the broadest cross-reactivity with 14/1-specific serum, based on the fact that close to 100% of Colorado and Hungary viruses were neutralized by 5 AUs. Conversely, 10 AUs of each heterologous serum were required to neutralize the 14/1 virus. Taken together, these results suggested that the 14/1 virus shared more neutralizing regions with the Colorado and Hungary viruses than did either of these viruses with the 14/1 virus. Interestingly, only anti-Hungary serum could not efficiently neutralize Colorado virus at any of the AU levels, even though 10 AUs of anti-Colorado serum efficiently neutralized Hungary virus. This result indicated that the Hungary virus shared comparatively fewer neutralizing epitopes with the Colorado virus than did the 14/1 virus. Although it would be necessary to examine more strains, the data suggested that some degree of cross-reactivity would likely be detected among all avian metapneumoviruses belonging to the 3 subgroups. It was also clear that using only 1 dilution of serum in the PRNA would have led to a substantially different interpretation.
The antigenic basis for the observed serum specificity and cross-reactivity was determined by Western blot analysis. As expected, the virus-specific responses were directed to proteins migrating in the 35-to 53-kD-molecular weight region. This would include the F and M proteins, both of which have been reported to be quite variable based on sequence analysis of avian metapneumovirus strains. 26 Interestingly, 1 major cross-reactive band was detected in the 18-kD region and, on the basis of its predicted molecular weight, may represent the SH protein. In the literature, this protein has been characterized as being hydrophobic and membrane-associated, with well-conserved N-terminus and membrane-spanning regions. 18 The C-terminus of the analogous protein in human respiratory syncytial virus is extracellularly orientated, and antibodies raised against this region react with both virus and intact infected cells. 8 Therefore, the possibility exists that this may represent a conserved, antigenic avian metapneumovirus protein and could potentially be used as a diagnostic reagent in serological assays. Confirmation of this observation would require the analysis of more sera.
In summary, on the basis of their avian origin and ease of preparation, QT-35 cells are a suitable substrate for avian metapneumovirus replication and have been successfully adapted for use in a variety serological assays. Preliminary studies demonstrated that these assays could be used for the diagnosis of avian metapneumovirus infections and to study antigenic relationships between stains.
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